These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35717519)

  • 1. ASO Author Reflections: Does Elevation of the Prognostic Factor Plasma Fibrinogen Level Reflect the Tumor Microenvironment at the Primary Site?
    Hoshino S; Matsuda S; Kawakubo H; Yamaguchi S; Nakamura K; Aimono E; Matsui K; Irino T; Fukuda K; Nakamura R; Okita H; Nishihara H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2022 Oct; 29(11):6905-6906. PubMed ID: 35717519
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Fibrinogen and Albumin Score Validated as a Prognostic Factor to Refine the Treatment Strategy for Esophageal Cancer Patients.
    Matsuda S; Takeuchi H; Kawakubo H; Takemura R; Maeda Y; Hirata Y; Kaburagi T; Egawa T; Nishi T; Ogura M; Miyasho T; Okamura A; Mayanagi S; Fukuda K; Nakamura R; Irino T; Wada N; Kitagawa Y
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):886-887. PubMed ID: 32761333
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevation of the Prognostic Factor Plasma Fibrinogen Reflects the Immunosuppressive Tumor Microenvironment in Esophageal Squamous Cell Carcinoma.
    Hoshino S; Matsuda S; Kawakubo H; Yamaguchi S; Nakamura K; Aimono E; Matsui K; Irino T; Fukuda K; Nakamura R; Okita H; Nishihara H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2022 Oct; 29(11):6894-6904. PubMed ID: 35672627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASO Author Reflections: Clinical Significance of Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Non-small Cell Lung Cancer.
    Iwasaki M; Ishihara S; Inoue M
    Ann Surg Oncol; 2022 Sep; 29(9):5708-5709. PubMed ID: 35614370
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Can the Association Between Obesity and Colorectal Cancer Be Explained by an Unfavorable Tumor Immune Microenvironment?
    Flaherty DC; Bilchik AJ
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):535-536. PubMed ID: 30523469
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: An Added Dimension to the Tumor Immune Microenvironment.
    Frankel TL
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):794-795. PubMed ID: 31628557
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Optimization of Tumor Therapy for the Specific Immune Microenvironment of Gastric Cancer.
    He X; Cao Y; Gu Y; Fang H; Wang J; Liu X; Lv K; Yu K; Fei Y; Lin C; Liu H; Zhang H; Li H; Xu J; Li R; He H
    Ann Surg Oncol; 2021 Oct; 28(11):6451-6452. PubMed ID: 33782801
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Colorectal Cancers with Extramural Vascular Invasion Are Associated with a Low Immune Microenvironment.
    Sonal S; Berger DL
    Ann Surg Oncol; 2022 Nov; 29(12):7383. PubMed ID: 35930115
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Targeting the Immunosuppressive Tumor Microenvironment for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancer.
    Chan CHF
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):759-760. PubMed ID: 32451943
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Prognostic Significance of Primary Tumor Infiltrating Lymphocytes in the Contemporary Melanoma Era.
    Straker RJ; Krupp K; Karakousis GC
    Ann Surg Oncol; 2022 Aug; 29(8):5217-5218. PubMed ID: 35303177
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Prognostic Impact of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer.
    Shida D
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):666-667. PubMed ID: 31359284
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of preoperative plasma fibrinogen level in patients with upper urinary tract urothelial carcinoma: A retrospective tumor marker prognostic study.
    Liu R; Zhou X; Zou L; Chen Q; Hu Y; Hu J; Wu X; Jiang H
    Int J Surg; 2019 May; 65():88-93. PubMed ID: 30951871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASO Author Reflections: Prognostic Value of Tumor Border Configuration in Colon Cancer.
    Qwaider YZ; Berger DL
    Ann Surg Oncol; 2021 Jun; 28(6):3415. PubMed ID: 33150551
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: A New Prognostic Factor for Pancreatic Cancer.
    Yoshiya S; Itoh S; Yoshizumi T; Mori M
    Ann Surg Oncol; 2021 Jun; 28(6):3208. PubMed ID: 33230752
    [No Abstract]   [Full Text] [Related]  

  • 15. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer.
    Wang H; Gao J; Bai M; Liu R; Li H; Deng T; Zhou L; Han R; Ge S; Huang D; Ba Y
    Platelets; 2014; 25(5):382-7. PubMed ID: 24001199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of plasma fibrinogen concentrations of patients with ST-elevation myocardial infarction and treated by primary percutaneous coronary intervention: a cautionary message.
    Ferraro S; Santagostino M; Marano G; Colli E; Vendramin C; Maffé S; Rossi L; Galvani M; Panteghini M; Bongo AS
    Scand J Clin Lab Invest; 2012 Sep; 72(5):355-62. PubMed ID: 22486807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment.
    Wen J; Yang Y; Ye F; Huang X; Li S; Wang Q; Xie X
    Breast; 2015 Dec; 24(6):745-50. PubMed ID: 26482138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASO Author Reflections: Circulating Tumor Cell Count is a Prognostic Factor in Patients with Resected Colorectal Cancer Liver Metastases.
    Arrazubi V
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):842. PubMed ID: 31659641
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: mLST8 is a Prognostic Biomarker and Involved in Tumor Progression in Hepatocellular Carcinoma.
    Yu XN; Shen XZ; Guo HY; Zhu JM
    Ann Surg Oncol; 2020 May; 27(5):1558-1559. PubMed ID: 32166592
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.
    Baumgartner JM; Riviere P; Kurzrock R
    Ann Surg Oncol; 2020 Sep; 27(9):3268-3269. PubMed ID: 32303875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.